NTLA
Intellia Therapeutics Inc
13.10$
+3.7%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -116.0% | – | -76.0% | +31.0% | +41.3% | +29.2% | -14.3% | -3.3% | +67.0% | -34.6% | -49.1% | – | |
| – | +7.7% | +1.9% | +3.5% | +4,100.6% | +7.1% | – | – | -2.0% | -92.4% | -63.4% | – | – | |
| – | -145.2% | – | -83.5% | -2,396.1% | – | – | -498.7% | – | – | -24.4% | -40.4% | – | |
| – | -4.1% | +0.3% | +2.1% | +10.5% | -5.3% | -7.2% | -10.5% | -2.4% | -6.4% | -8.9% | +2.3% | – | |
| – | -1.4% | +7.2% | +2.3% | -4.1% | +6.4% | -10.6% | -6.2% | +12.2% | +8.4% | +5.3% | +8.6% | – | |
| – | -3.8% | +3.6% | +2.1% | -68.8% | -27.4% | +323.6% | -68.2% | +6.0% | +149.9% | -2.0% | +6.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -93.9% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.